about
Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative StudyLifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort.Predictors of Long-Term Change in Adult Cognitive Performance: Systematic Review and Data from the Northern Finland Birth Cohort 1966.Sex differences in Wisconsin Schizotypy Scales--a meta-analysis.Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illnessLinking the developmental and degenerative theories of schizophrenia: association between infant development and adult cognitive decline.Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis.Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort.Aberrant Functional Connectivity in the Default Mode and Central Executive Networks in Subjects with Schizophrenia - A Whole-Brain Resting-State ICA Study.Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic ReviewLongitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function.Seasonal variation in affective and other clinical symptoms among high-risk families for bipolar disorders in an Arctic population.Brain structural deficits and working memory fMRI dysfunction in young adults who were diagnosed with ADHD in adolescenceSerum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study.Verbal learning and memory and their associations with brain morphology and illness course in schizophrenia spectrum psychoses.Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis.Do adverse perinatal events predict mortality in schizophrenia during midlife?Search for protective factors for psychosis - a population-based sample with special interest in unaffected individuals with parental psychosis.Prognosis of schizophrenia spectrum disorder may not be predetermined during early development--the Northern Finland Birth Cohort 1966.Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.White matter structure in young adults with familial risk for psychosis - The Oulu Brain and Mind Study.Changes in verbal learning and memory in schizophrenia and non-psychotic controls in midlife: A nine-year follow-up in the Northern Finland Birth Cohort study 1966.Negative symptoms and their predictors in schizophrenia within the Northern Finland 1966 Birth Cohort.Young people at risk for psychosis: case finding and sample characteristics of the Oulu Brain and Mind Study.Association between the duration of untreated psychosis and short- and long-term outcome in schizophrenia within the Northern Finland 1966 Birth Cohort.Author's reply: To PMID 25252316.Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study.Use of antidepressant medication and suicidal ideation-the Northern Finland Birth Cohort 1966.Association between family history of psychiatric disorders and long-term outcome in schizophrenia - The Northern Finland Birth Cohort 1966 study.Default mode network in young people with familial risk for psychosis--the Oulu Brain and Mind study.Use of antipsychotic medication and suicidality--the Northern Finland Birth Cohort 1966.Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife.Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort.How to use bibliometric methods in evaluation of scientific research? An example from Finnish schizophrenia research.F128. THE AGE OF ONSET OF SCHIZOPHRENIA SPECTRUM DISORDERS.S230. LONG-TERM ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA: BENEFITS, RISKS AND FOLLOW-UP: DATA FROM FINNISH COHORT STUDIES AND SYSTEMATIC REVIEW.T136. DO VITAMIN D SUPPLEMENTATION DURING THE FIRST YEAR OF LIFE PREDICT COGNITION IN PSYCHOSES DURING MIDLIFE?Under-utilized opportunities to optimize medication management in long-term treatment of schizophrenia.
P50
Q28597689-1B49F632-6496-4CF5-99AD-424FD7821076Q30835228-ACD317B9-98B9-4D34-BA60-E13F4F7C454BQ31035188-54B627F3-8816-4EE9-A699-67B48746D37BQ33707620-A7BCE811-911B-4FAB-BED3-7A5075208895Q33921159-226F97E6-C7C1-49F8-97A9-4C7B5AEC5C68Q33950987-06AD0ACB-9B3C-4F6F-9AFD-CC4CD0EA21B3Q34322975-58346B97-E165-40CD-8836-3D9C872D6E3AQ34681347-1D572ED8-E42D-4C8C-9712-90B7B7416E63Q34863670-7C511237-C26D-4B7F-A814-D84B527A41D1Q35124330-BF51F7BA-709F-435C-A237-4DBBAF0DD3A8Q35673737-944E2717-E6E4-4D32-8E7D-279D72F27678Q36157849-F0A1E6A5-8AD2-412B-95FD-E8BFEA15FBC6Q36303909-866DA2A5-809C-449A-8AA5-608AF0D77B5AQ36863845-143180E4-2F57-4CD9-9376-4B4E4C2A2DD3Q37524068-1D5F408F-BE32-41CC-B653-6A6D657015DEQ38473103-9A1B3996-6D2D-4049-A12B-9262646EA1E4Q38724029-BC9E4FA6-3376-4E42-8210-BD4057F7AFABQ39267126-AFC2DF73-4258-49DA-A8CD-9D7DE382721CQ39338203-881B05BF-B2DC-4C4A-AC02-EE95AB5C2D2EQ39400096-862ECC32-ECAB-451A-B3EE-2D9E773670B0Q40857117-21C88B2C-1C52-4EC2-BADF-BCE7A546100DQ41062952-BB3CD2BA-C69D-4235-BF28-FA104E1FC402Q41525640-CDFF6D44-C82A-4660-985A-45DA4D47A0E1Q41591655-4EEE8398-E81A-4006-B201-E90DD4EA00C5Q43059912-D9042F90-FCEA-49F5-AC1D-32A64A144B7BQ44351484-BEF86B5E-A0F4-4754-A46F-2E9250292750Q44571706-559350B0-E49E-485E-ADD7-DE81E3C5E471Q45229511-BED6B741-67CE-40CC-B3A6-7AD278CA10F5Q46827879-319A176E-C35D-47C6-84A9-231FA6BC9B2DQ47805402-C5BE9E28-E6CD-48F7-A807-D8F51D073D24Q47835159-B965F66D-8D2A-46DB-8DE4-AE0792B4F84AQ48251463-31BE262B-4D4F-4FCD-9BCC-0AA4D471CA01Q48628524-CEEEA8DF-F9A7-4514-9144-5FEDB4FE753BQ49590921-C401E792-FD60-4DE7-AEA8-22E9C2995C8BQ51846524-84E6ABA5-280C-4836-A9CA-843F8B40B447Q53213484-83DBD5ED-6A28-425B-8913-2886EF49FD38Q55017610-28C77F16-49B9-48EF-833A-512369A0EF2AQ55081575-8E9613C7-DEAB-4944-ADEC-6B48D9141D17Q55166564-FE1C5820-3032-47E7-912F-DA2489994828Q55339046-EBD1BBA3-876F-41C6-8A83-9811D7777FEB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Erika Jääskeläinen
@ast
Erika Jääskeläinen
@en
Erika Jääskeläinen
@es
Erika Jääskeläinen
@nl
type
label
Erika Jääskeläinen
@ast
Erika Jääskeläinen
@en
Erika Jääskeläinen
@es
Erika Jääskeläinen
@nl
prefLabel
Erika Jääskeläinen
@ast
Erika Jääskeläinen
@en
Erika Jääskeläinen
@es
Erika Jääskeläinen
@nl
P106
P21
P31
P496
0000-0001-5760-7389